Langerhans cell histiocytosis (LCH) is a rare cancer involving dendritic cells, a type of white blood cell that usually helps defend against infections. The current standard of care for LCH, chemotherapy, cures fewer than half of patients. “Our research team…
Read More
“This 5-minute tapping routine helped me handle post-lockdown overwhelm”
Tapping therapy is said to help ease stress and feelings of being overwhelmed by connecting the mind and body. Here’s how to do it in just five minutes. “I am feeling overwhelmed,” I say to myself into my Zoom camera…
Read More
What Is Craniosacral Therapy?
If you have ever been to a chiropractor or massage therapist, you may have experienced craniosacral therapy (CST). However, if this sounds alien to you, and you live with chronic migraines, neck pain, neuralgia, or even are suffering with side effects…
Read More
Discovery of potential new combination therapy for leukemia
WEHI researchers have discovered why some leukemia cells are resistant to new “SMAC-mimetic’ anti-cancer agents, a finding which could improve the use of these drugs in the clinic. The team discovered that the ‘drug pump’ protein MDR1 makes acute myeloid…
Read More
Bespoke neuroblastoma therapy weaponizes cell metabolism
Preclinical research from VCU Massey Cancer Center published recently in the Proceedings of the National Academy of Sciences shows that the combination of two existing drugs can exploit the metabolic ‘hunger’ of a particularly aggressive type of neuroblastoma to kill…
Read More
Poor Survival With COVID in Patients Who Have Had HSCT
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Among individuals who have received a hematopoietic stem cell transplant (HSCT), often used in the treatment of blood cancers, rates of survival are poor for those…
Read More
Potential combined drug therapy for lung cancer
Most lung cancers are of a type called non-small-cell lung carcinoma (NSCLC). This type of cancer is relatively insensitive to chemotherapy, so NSCLC therapies are usually based on drug treatment. Alectinib is a drug commonly used for treating patients with…
Read More
Immune checkpoint inhibitor therapy tied to cardiac event risk
(HealthDay)—Immune checkpoint inhibitor (ICI) treatment is associated with increased cardiac events among patients with lung cancer and malignant melanoma, according to a study published online Dec. 9 in the European Heart Journal. Maria D’Souza, M.D., from the Copenhagen University Hospital…
Read More
Cancer: Tumor driver promoting EMT, metastasis and resistance to therapy
Cancer metastasis, which is the dissemination of tumor cells into distant organs, is the leading cause of mortality in cancer patients. To undergo metastasis, cells must leave the primary tumor, circulate into the blood, colonize distant organs, and form distant…
Read More
Potential cancer therapy may boost immune response
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according to a study led by…
Read More